Immune responses of a chimaeric protein vaccine containing Mycoplasma hyopneumoniae antigens and LTB against experimental M. hyopneumoniae infection in pigs

Vaccine

Volumn 32, Issue 36, 2014, Pages 4689-4694

  Marchioro, Silvana B ^a,b   Sácristan, Rubén Del Pozo ^a   Michiels, Annelies ^a   Haesebrouck, Freddy ^a   Conceição, Fabricio R ^b   Dellagostin, Odir A ^b   Maes, Dominiek ^a  

^a GHENT UNIVERSITY   (Belgium)

^b FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

Chimaeric protein; Enzootic pneumonia; Mycoplasma hyopneumoniae; Recombinant vaccine; Subunit based vaccine

Indexed keywords

BACTERIAL ANTIGEN; BACTERIN; CHIMERIC PROTEIN; ESCHERICHIA ENTEROTOXIN; HEAT SHOCK PROTEIN P42; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; PROTEIN NRDF; PROTEIN P97; RECOMBINANT PROTEIN; SUVAXYN; UNCLASSIFIED DRUG; BACTERIAL VACCINE; BACTERIUM ANTIBODY; ENTEROTOXIN; HYBRID PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG EFFICACY; IMMUNE RESPONSE; IMMUNIZATION; MALE; MYCOPLASMA HYOPNEUMONIAE; MYCOPLASMAL PNEUMONIA OF SWINE; NONHUMAN; PIGLET; PRIORITY JOURNAL; ANIMAL; BLOOD; ESCHERICHIA COLI; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; LUNG LAVAGE; MICROBIOLOGY; PNEUMONIA OF SWINE, MYCOPLASMAL; RANDOMIZATION; SWINE; VETERINARY;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; BRONCHOALVEOLAR LAVAGE FLUID; ENTEROTOXINS; ESCHERICHIA COLI; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INJECTIONS, INTRAMUSCULAR; MALE; MYCOPLASMA HYOPNEUMONIAE; PNEUMONIA OF SWINE, MYCOPLASMAL; RANDOM ALLOCATION; RECOMBINANT FUSION PROTEINS; SWINE;

EID: 84904576096     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.05.072     Document Type: Article

References (30)

1. Maes D., Segales J., Meyns T., Sibila M., Pieters M., Haesebrouck F. Control of Mycoplasma hyopneumoniae infections in pigs. Vet Microbiol 2008, 126(January (4)):297-309.
2. Haesebrouck F., Pasmans F., Chiers K., Maes D., Ducatelle R., Decostere A. Efficacy of vaccines against bacterial diseases in swine: what can we expect. Vet Microbiol 2004, 100:255-268.
3. Meyns T., Dewulf J., de K.A., Calus D., Haesebrouck F., Maes D. Comparison of transmission of Mycoplasma hyopneumoniae in vaccinated and non-vaccinated populations. Vaccine 2006, 24(November (49-50)):7081-7086.
4. Villarreal I., Meyns T., Dewulf J., Vranckx K., Calus D., Pasmans F., et al. The effect of vaccination on the transmission of Mycoplasma hyopneumoniae in pigs under field conditions. Vet J 2011, 188:48-52.
5. Villarreal I., Maes D., Vranckx K., Calus D., Pasmans F., Haesebrouck F. Effect of vaccination of pigs against experimental infection with high and low virulence Mycoplasma hyopneumoniae strains. Vaccine 2011, 29(February (9)):1731-1735.
6. Villarreal I., Maes D., Meyns T., Gebruers F., Calus D., Pasmans F., et al. Infection with a low virulent Mycoplasma hyopneumoniae isolate does not protect piglets against subsequent infection with a highly virulent M. hyopneumoniae isolate. Vaccine 2009, 27:1875-1879.
7. Chen Y.L., Wang S.N., Yang W.J., Chen Y.J., Lin H.H., Shiuan D. Expression and immunogenicity of Mycoplasma hyopneumoniae heat shock protein antigen P42 by DNA vaccination. Infect Immun 2003, 71:1155-1160.
8. Conceição F.R., Moreira A.N., Dellagostin O.A. A recombinant chimera composed of R1 repeat region of Mycoplasma hyopneumoniae P97 adhesin with Escherichia coli heat-labile enterotoxin B subunit elicits immune response in mice. Vaccine 2006, 24:5734-5743.
9. Fagan P.K., Walker M.J., Chin J., Eamens G.J., Djordjevic S.P. Oral immunization of swine with attenuated Salmonella typhimurium aroA SL3261 expressing a recombinant antigen of Mycoplasma hyopneumoniae (NrdF) primes the immune system for a NrdF specific secretory IgA response in the lungs. Microb Pathog 2001, 30:101-110.
10. Okamba F.R., Arella M., Music N., Jia J.J., Gottschalk M., Gagnon C.A. Potential use of a recombinant replication-defective adenovirus vector carrying the C-terminal portion of the P97 adhesin protein as a vaccine against Mycoplasma hyopneumoniae in swine. Vaccine 2010, 28:4802-4809.
11. Shimoji Y., Oishi E., Muneta Y., Nosaka H., Mori Y. Vaccine efficacy of the attenuated Erysipelothrix rhusiopathiae YS-19 expressing a recombinant protein of Mycoplasma hyopneumoniae P97 adhesin against mycoplasmal pneumonia of swine. Vaccine 2003, 21:532-537.
12. Simionatto S., Marchioro S.B., Galli V., Brum C.B., Klein C.S., Rebelatto R., et al. Immunological characterization of Mycoplasma hyopneumoniae recombinant proteins. Comp Immunol Microbiol 2012, 35:209-216.
13. Chen A.Y., Fry S.R., Daggard G.E., Mukkur T.K. Evaluation of immune response to recombinant potential protective antigens of Mycoplasma hyopneumoniae delivered as cocktail DNA and/or recombinant protein vaccines in mice. Vaccine 2008, 26:4372-4378.
14. Ogawa Y., Oishi E., Muneta Y., Sano A., Hikono H., Shibahara T., et al. Oral vaccination against mycoplasmal pneumonia of swin using a live Erysipelothrix rhusiopathiae vaccine strain as a vector. Vaccine 2009, 27:4543-4550.
15. Cox E., Verdonck F., Vanrompay D., Goddeeris B. Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa. Vet Res 2006, 37:511-539.
16. Simmons C.P., Ghaem-Magami M., Petrovska L., Lopes L., Chain B.M., Williams N.A., et al. Immunomodulation using bacterial enterotoxins. Scand J Immunol 2001, 53:218-226.
17. da Hora V.P., Conceição F.R., Dellagostin O.A., Doolan D.L. Non-toxic derivatives of LT as potent adjuvants. Vaccine 2011, 29:1538-1544.
18. Marchioro S.B., Simionatto S., Galli V., Conceição F.R., Brum C.B., Fisch A., et al. Production and characterization of recombinant transmembrane proteins from Mycoplasma hyopneumoniae. Vet Microbiol 2012, 155:44-52.
19. Simionatto S., Marchioro S.B., Galli V., Hartwig D.D., Carlessi R.M., Munari F.M., et al. Cloning and purification of recombinant proteins of Mycoplasma hyopneumoniae expressed in Escherichia coli. Protein Expr Purif 2010, 69:132-136.
20. Stark K.D., Nicolet J., Frey J. Detection of Mycoplasma hyopneumoniae by air sampling with a nested PCR assay. Appl Environ Microbiol 1998, 64:543-548.
21. Meyns T., Maes D., Calus D., Ribbens S., Dewulf J., Chiers K., et al. Interactions of highly and low virulent Mycoplasma hyopneumoniae isolates with the respiratory tract of pigs. Vet Microbiol 2007, 120:87-95.
22. Vicca J., Stakenborg T., Maes D., Butaye P., Peeters J., de K.A., et al. Evaluation of virulence of Mycoplasma hyopneumoniae field isolates. Vet Microbiol 2003, 97:177-190.
23. Halbur P.G., Paul P.S., Meng X.J., Lum M.A., Andrews J.J., Rathje J.A. Comparative pathogenicity of nine US porcine reproductive and respiratory syndrome virus (PRRSV) isolates in a five-week-old cesarean-derived, colostrum-deprived pig model. J Vet Diagn Invest 1996, 8:11-20.
24. Hannan P.C., Bhogal B.S., Fish J.P. Tylosin tartrate and tiamutilin effects on experimental piglet pneumonia induced with pneumonic pig lung homogenate containing mycoplasmas, bacteria and viruses. Res Vet Sci 1982, 33:76-88.
25. Morris C.R., Gardner I.A., Hietala S.K., Carpenter T.E., Anderson R.J., Parker K.M. Seroepidemiologic study of natural transmission of Mycoplasma hyopneumoniae in a swine herd. Prev Vet Med 1995, 21:323-337.
26. Kobisch M., Tillon J.P., Vannier P. Mycoplasma suipneumoniae enzootic pneumonia in pig - rapid diagnosis and research of antibodies. Recueil Med Vet 1978, 154:847-852.
27. Marois C., Dory D., Fablet C., Madec F., Kobisch M. Development of a quantitative Real-Time TaqMan PCR assay for determination of the minimal dose of Mycoplasma hyopneumoniae strain 116 required to induce pneumonia in SPF pigs. J Appl Microbiol 2010, 108:1523-1533.
28. Vranckx K., Maes D., Marchioro S.B., Villarreal I., Chiers K., Pasmans F., et al. Vaccination reduces macrophage infiltration in bronchus-associated lymphoid tissue in pigs infected with a highly virulent Mycoplasma hyopneumoniae strain. BMC Vet Res 2012, 12:8.
29. Le Carrou J., Laurentie M., Kobisch M., Gautier-Bouchardon A.V. Persistence of Mycoplasma hyopneumoniae in experimentally infected pigs after marbofloxacin treatment and detection of mutations in the parC gene. Antimicrob Agents Chemother 2006, 50:1959-1966.
30. Marois C., Le C.J., Kobisch M., Gautier-Bouchardon A.V. Isolation of Mycoplasma hyopneumoniae from different sampling sites in experimentally infected and contact SPF piglets. Vet Microbiol 2007, 120:96-104.